MedLabs InnoTalk Series
CFIUS and Trade Controls
in Life Science
Episode One Wednesday, August 18th, Online Zoom Webinar
Episode Two Wednesday, September 1st, Online Zoom Webinar
In this two-episode InnoTalk Event, we are pleased to invite Judith Allison Lee, Co-Chair at the International Trade Regulation and Compliance Practice Group and Partner at Gibson, Dunn & Crutcher LLP, and Carl Valenstein, Partner at Morgan, Lewis & Bockius. The webinars will guide you through the details of FIRRMA as well as the intention of the rules, how they are impacting investors and companies, and what to expect in the future.
Each webinar is one hour in length, consisting of a welcome intro by Dr. Ella Li, CEO of ZGC Capital, a 40-minute informative speech by the speaker, and a Q&A session.
ATTENDEES WILL LEARN
Episode One Judith Alison Lee: How Startups Managing the Sanctions, Export Controls and CFIUS Risks
Definitions of Economic Sanctions, Sanctions, Export Controls and CFIUS Risks
How trade controls and regulations impact global business
Whether a company is ready to answer investors’ questions with respect to national security concerns that may be implicated by its business in the event that foreign investors acquire a minority or controlling interest.
How to identify whether a product/technology is potentially covered by an export license requirement
Advices to U.S. companies that operate within the biotechnology and life science industries
Episode Two Carl Valenstein: CFIUS issues in Life Science Investment and Venture Capital Transactions
CFIUS due diligence and standard contractual provisions from the company and investor perspectives Increased risk of CFIUS reviews of non-notified transactions
Difference between mandatory and voluntary CFIUS filings
Key issues for life sciences companies
Key planning techniques for not having a “covered transaction”
Judith Alison Lee
Co-Chair at the International Trade Regulation and Compliance Practice Group,
Partner at Gibson, Dunn & Crutcher, LLP
Judith Alison Lee is Co-Chair of the International Trade Regulation and Compliance Practice Group and a partner in Gibson, Dunn & Crutcher, LLP’s Washington, DC office. Her areas of expertise include: OFAC, FCPA, export controls, CFIUS, and blockchain and cryptocurrency issues.
Ms. Lee has been consistently selected by Chambers Global-Business as a leading lawyer for USA International Trade in Export Controls and Economic Sanctions, and by Chambers and Partners as a leading International Trade Lawyer in Chambers USA: America's Leading Lawyers for Business Guide. She is former Co-Chair of the IBA’s Export Controls, Sanctions and Anti-Corruption Subcommittee, and former Co-Chair of the ABA’s Export Controls and Embargoes Committee.
Partner at Morgan, Lewis & Bockius
Carl Valenstein focuses his practice on domestic and international corporate and securities matters, mergers and acquisitions, project development, and transactional finance. He counsels extensively in the life science, telecom/electronics, and maritime industries, and has worked broadly in Latin America, the Caribbean, Europe, Africa, Asia, and the Middle East. He previously served as co-chair of the International Section of the Boston Bar Association and co-chairs the firm’s environmental, social, and governance (ESG) and sustainable business and Cuba initiatives. Carl is the leader of the Boston office corporate and business transactions practice.